Skip to content
Search

Latest Stories

RPS publishes roadshow report, membership vote on Royal College status set for Q1 2025

RPS gathers feedback on its proposals for change and its ambition to transition into the Royal College of Pharmacy.

Pharmacists and pharmaceutical scientists provide feedback on proposed changes to the RPS constitution and governance (C&G)  

The Royal Pharmaceutical Society (RPS) has released a comprehensive report summarizing the discussions and feedback gathered during a series of engagement events held across Great Britain in October and November, focused on its proposals for change and its ambition to transition into the Royal College of Pharmacy.


The engagement initiative included 15 roadshow events in various cities across England, Wales, and Scotland, as well as online events and meeting presentations.

According to the report, the roadshows attracted over 1,000 registrations, with more than 540 attendees.

Hosted by the RPS leadership team and elected officials, these events brought together a diverse group of pharmacists, foundation trainees, pharmaceutical scientists, and other stakeholders from different settings and sectors.

Participants shared their thoughts on the RPS’s proposals to reform its constitution and governance, raised critical questions, and explored the implications of the proposed changes.

RPS president Professor Claire Anderson highlighted the significance of these roadshows, stating that they have provided “an invaluable opportunity to connect with members and non-members and hear their thoughts about the proposed changes, and what becoming a Royal College would mean to them and for pharmacy.”

“We are grateful for the enthusiasm, insights, and constructive feedback shared by everyone who came to one of the events. This dialogue is vital as we move forward with our proposals for change and seek to elevate pharmacy and champion our collective impact on patient care.”

The RPS said that it has taken into account the questions and feedback from members and stakeholders in the final drafting of their proposals for change, which will be published this month.

As part of the next steps in the constitution and governance (C&G) process, RPS plans to launch a campaign to inform and engage its members, leading up to a membership vote on the Royal College status in Q1 2025.

  • The current proposals include making these key changes:
  • Transforming RPS into a registered charity, overseen by a Board of Trustees.
  • Seeking to become the Royal College of Pharmacy.
  • Retaining an elected body for professional leadership, transitioning from the current Assembly to a Senate with clearly defined roles.
  • Maintaining National Boards, to be renamed National Councils, focusing on devolved national health policy.
  • Establishing Pharmaceutical Press as a wholly owned subsidiary.

For the changes to be enacted, a two-thirds majority of members’ votes in favour is required, along with approval from the Privy Council.

Additionally, obtaining charitable status necessitates agreement from charity regulators in England, Wales, and Scotland.

More For You

 RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care

Professor Tony Avery OBE

Pic credit: RPS

Professor Tony Avery OBE awarded RPS Honorary Fellowship

The Royal Pharmaceutical Society (RPS) Assembly has awarded an Honorary Fellowship to Professor Tony Avery OBE in recognition of his outstanding contribution to prescribing safety and patient care.

The Honorary Fellowship is given to those who are not eligible for membership of the Society but have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.

Keep ReadingShow less
US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less